-
1Academic Journal
Authors: L. T. Khamidova, N. V. Rybalko, A. A. Ivannikov, E. A. Bashirova, G. R. Ramazanov, A. A. Kanibolotskii, Л. Т. Хамидова, Н. В. Рыбалко, А. А. Иванников, Е. А. Баширова, Г. Р. Рамазанов, А. А. Каниболоцкий
Source: Medical Visualization; Том 28, № 3 (2024); 106-116 ; Медицинская визуализация; Том 28, № 3 (2024); 106-116 ; 2408-9516 ; 1607-0763
Subject Terms: фиброз миокарда, atrial cardiomyopathy, speckle-tracking echocardiography, myocardial fibrosis, предсердная кардиомиопатия, спекл-трекинг-эхокардиография
File Description: application/pdf
Relation: https://medvis.vidar.ru/jour/article/view/1417/881; https://medvis.vidar.ru/jour/article/downloadSuppFile/1417/2237; https://medvis.vidar.ru/jour/article/downloadSuppFile/1417/2238; https://medvis.vidar.ru/jour/article/downloadSuppFile/1417/2239; https://medvis.vidar.ru/jour/article/downloadSuppFile/1417/2240; Воеводина И.В., Майчук Е.Ю., Иванова О.С. Распространенность факторов риска сердечно-сосудистых заболеваний и их структура среди здоровых женщин. Основные результаты проекта “Три возраста женщины”. Клиническая практика. 2020; 11 (1): 73–80. https://doi.org/10.17816/clinpract18967; Пирадов М.А., Максимова М.Ю., Танашян М.М. Инсульт: пошаговая инструкция. М.: ГЭОТАР-Медиа, 2019. 272 с.; Козловский В.И., Занько С.Н., Крылов Ю.В. Фармакоэкономика в кардиологии, онкологии и акушерстве. Изд. 2-е. Витебск: ВГМУ, 2016. 285 с.; Feske S.K. Ischemic stroke. Am. J. Med. 2021; 134 (12): 1457–1464. https://doi.org/10.1016/j.amjmed.2021.07.027; Ntaios G. Embolic stroke of undetermined source: JACC review topic of the week. J. Am. Coll. Cardiol. 2020; 75 (3): 333–340https://doi.org/10.1016/j.jacc.2019.11.024; Kawakami H., Inoue K., Nagai T. et al. Left atrial dysfunction still exists in patients who obtain normal left atrial volume after successful ablation of atrial fibrillation. Eur. Heart J. 42 (Suppl. 1): ehab724.0504. https://doi.org/10.1093/eurheartj/ehab724.0504; To A.C., Flamm S.D., Marwick T.H., Klein A.L. Clinical utility of multimodality LA imaging: assessment of size, function, and structure. JACC Cardiovasc. Imaging. 2011; 4 (7): 788–798. https://doi.org/10.1016/j.jcmg.2011.02.018; Ancona R., Comenale Pinto S., Caso P. et al. Left atrium by echocardiography in clinical practice: from conventional methods to new echocardiographic techniques. ScientificWorldJournal. 2014; 2014:451042. https://doi.org/10.1155/2014/451042; Bouwmeester S., van der Stam J.A., van Loon S.L.M. et al. Left atrial reservoir strain as a predictor of cardiac outcome in patients with heart failure: the HaFaC cohort study. BMC Cardiovasc. Disord. 2022; 22 (1): 1–10. https://doi.org/10.1186/s12872-022-02545-5; Oike F., Usuku H., Yamamoto E. et al. Clinical significance of left atrial function estimated by two dimensional speckle tracking echocardiography for diagnosis of concomitant transthyretin amyloid cardiomyopathy in patients with aortic stenosis. Circulation. 2021; 144 (Suppl. 1): A10841–A10841. https://doi.org/10.1002/ehf2.13909; Lang R.M., Badano L.P., Mor-Avi V. et al. Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. Eur. Heart J. – Cardiovasc. Imaging. 2015. 16 (3): 233–271. https://doi.org/10.1016/j.echo.2014.10.003; Медведев П.И., Алехин М.Н., Сидоренко Б.А. Диагностические возможности спекл-трекинг эхокардиографии у больных ишемической болезнью сердца. Кардиология. 2016; 56 (2): 79–84. https://doi.org/10.18565/cardio.2016.2.79-84; Ritchie R.H., Abel E.D. Basic mechanisms of diabetic heart disease. Circ. Res. 2020; 126 (11): 1501–1525. https://doi.org/10.1161/CIRCRESAHA.120.315913; Zhang M.J., Norby F.L., Lutsey P.L. et al. Association of left atrial enlargement and atrial fibrillation with cognitive function and decline: the ARIC-NCS. J. Am. Heart Assoc. 2019; 8 (23): e013197. https://doi.org/10.1161/JAHA.119.013197; Dal Porto M., Dematte C., Maines M. et al. Left atrial functional remodeling assessed by echocardiography in patients undergoing ablation for atrial fibrillation: correlation with the presence of fibrosis and invasive atrial pressure. Eur. Heart J.-Cardiovasc. Imaging. 2022; 23 (Suppl.1): jeab289.103. https://doi.org/10.1093/ehjci/jeab289.103; Jia F., Chen A., Zhang D. et al. Prognostic Value of Left Atrial Strain in Heart Failure: A Systematic Review and Meta-Analysis. Front. Cardiovasc. Med. 2022; 9: 935103. https://doi.org/10.3389/fcvm.2022.935103; https://medvis.vidar.ru/jour/article/view/1417
-
2Academic Journal
Authors: B. A. Tatarsky, D. A. Napalkov, Б. А. Татарский, Д. А. Напалков
Source: Rational Pharmacotherapy in Cardiology; Vol 19, No 1 (2023); 83-88 ; Рациональная Фармакотерапия в Кардиологии; Vol 19, No 1 (2023); 83-88 ; 2225-3653 ; 1819-6446
Subject Terms: предсердная кардиомиопатия, cardioembolic stroke, atrial cardiomyopathy, кардиоэмболический инсульт
File Description: application/pdf
Relation: https://www.rpcardio.com/jour/article/view/2883/2396; Di Carlo Bellino L, Zaninell F, Baldereschi A, et al. Fibrillazione Atriale in Italia. Prevalence of atrial fibrillation in the Italian elderly population and projections from 2020 to 2060 for Italy and the European Union: the FAI Project. Europace. 2019;21(10):1468-75. DOI:10.1093/europace/euz141; Sumeet S, Havmoeller R, Narayanan K, et al. Worldwide epidemiology of atrial fibrillation: a Global Burden of Disease 2010 Study. Circulation. 2014;129(8):837-47. DOI:10.1161/CIRCULATIONAHA.113.005119.; BalL J, Carrington MJ, McMurray JIW, et al. Atrial fibrillation: profile and burden of an evolving epidemic in the 21st century Int J Cardiol. Int J Cardiol. 2013;167(5):1807-24. DOI:10.1016/j.ijcard.2012.12.093.; Hindricks G, Potpara T, Dagres N, et al. 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association of Cardio-Thoracic Surgery (EACTS) Eur Heart J. 2021;42(5):373-498. DOI:10.1093/eurheartj/ehaa612.; Cowan J, Wu J, Hall M, et al. A 10 year study of hospitalized atrial fibrillation-related stroke in England and its association with uptake of oral anticoagulation. Eur Heart J. 2018;39(32):2975-83. DOI:10.1093/eurheartj/ehy411; Freedman B. Major progress in anticoagulant uptake for atrial fibrillation at last: does it translate into stroke prevention? Eur Heart J. 2018;39(32):2984-86. DOI:10.1093/eurheartj/ehy487.; Chamberlain AM, Gersh BJ, Alonso A, et al. Decade-long trends in atrial fibrillation incidence and survival: a community study. Am J Med. 2015;128(3):260-7.e1. DOI:10.1016/j.amjmed.2014.10.030.; Marcucci M, Lip GYH, Nieuwlaat R, et al. Stroke and bleeding risk co-distribution in real-world patients with atrial fibrillation: the Euro Heart Survey. Am J Med. 2014;127(10):979-86.e2 42. DOI:10.1016/j.amjmed.2014.05.003.; Olesen JB, Lip GYH, Lindhardsen J, et al. Risks of thromboembolism and bleeding with thromboprophylaxis in patients with atrial fibrillation: a net clinical benefit analysis using a ‘real world’ nationwide cohort study. Thromb Haemost. 2011;106(4):739-49. DOI:10.1160/TH11-05-0364; Chugh SS, Havmoeller R, Narayanan K, et al. Worldwide epidemiology of atrial fibrillation: a Global Burden of Disease 2010 Study. Circulation 2014;129(8):837-47. DOI:10.1161/CIRCULATIONAHA.113.005119.; Singer DE, Chang Y, Borowsky LH, et al. A new risk scheme to predict ischemic stroke and other thromboembolism in atrial. J Am Heart Assoc. 2013.21;2(3):e000250. DOI:10.1161/JAHA.113.000250.; Brambatti M, Connolly SJ, Gold MR, et al., ASSERT Investigators. Temporal relationship between subclinical atrial fibrillation and embolic events. Circulation 2014;129(21):2094-9. DOI:10.1161/CIRCULATIONAHA.113.007825.; Martin DT, Bersohn MM, Waldo AL, et al. IMPACT Investigators. Randomized trial of atrial arrhythmia monitoring to guide anticoagulation in patients with implanted defibrillator and cardiac resynchronization devices. Eur Heart J. 2015;36(26):1660-8. DOI:10.1093/eurheartj/ehv115.; Turakhia MP, Ziegler PD, Schmitt SK, et al. Atrial fibrillation burden and short-term risk of stroke: case-crossover analysis of continuously recorded heart rhythm from cardiac electronic implanted devices. Circ Arrhythm Electrophysiol. 2015;8(5):1040-7. DOI:10.1161/CIRCEP.114.003057.; Kottkamp H. Fibrotic atrial cardiomyopathy: a specific disease/syndrome supplying substrates for atrial fibrillation, atrial tachycardia, sinus node disease, AV node disease, and thromboembolic complications. J. Cardiovasc. Electrophysiol. 2012;23(7):797-9. DOI:10.1111/j.1540-8167.2012.02341.x.; Alkhouli M, Alqahtani F, Aljohani S, et al. Burden of atrial fibrillation-associated ischemic stroke in the United States. JACC Clin Electrophysiol. 2018;4:618–625. DOI:10.1016/j.jacep.2018.02.021.4.; Friberg L, Rosenqvist M, Lip GYH, Net clinical benefit of warfarin in patients with atrial fibrillation: a report from the Swedish atrial fibrillation cohort study. Circulation. 2012;125:2298–2307. DOI:10.1161/CIRCULATIONAHA.111.055079.; Glotzer TV, Daoud EG, Wyse GD, et al. The relationship between daily atrial tachyarrhythmia burden from implantable device diagnostics and stroke risk: the TRENDS study. Circ. Arrhythm. Electrophysiol. 2009;2:474–480. DOI:10.1161/CIRCEP.109.849638.; Suzuki T, Yamazaki T, Ogawa S, et al. Echocardiographic predictors of frequency of paroxysmal atrial fibrillation (AF) and its progression to persistent AF in hypertensive patients with paroxysmal AF: results from the Japanese Rhythm Management Trial II for Atrial Fibrillation (J‑RHYTHM II Study). HeartRhythm. 2011;8(12):1831-6. DOI:10.1016/j.hrthm.2011.07.035.; Ganesan AN, Chew DP, Hartshorne T,et al. The impact of atrial fibrillation type on the risk of thromboembolism, mortality, and bleeding: a systematic review and meta-analysis. Eur. Heart J 2016.37;20:1591–1602. DOI:10.1093/eurheartj/ehw007.; Darlington A, McCauley MD. Atrial Cardiomyopathy: An Unexplored Limb of Virchow's Triad for AF. Stroke Prophylaxis. 2020;7:Art11 DOI:org/10.3389/fcvm.2020.00011.; Teh AW, Kistler PM, Lee G, et al. Long-term effects of catheter ablation for lone atrial fibrillation: Progressive atrial electroanatomic substrate remodeling despite successful ablation. Heart Rhythm. 2012;9:473–80. DOI:10.1016/j.hrthm.2011.11.013.; Tandon K, Tirschwell D, Longstreth WT, et al. Embolic stroke of undetermined source correlates to atrial fibrosis without atrial fibrillation. Neurology. 2019;93:e381–e387. DOI:10.1212/WNL.000000000000782.; Chao TF, Liu CE, Chen SY, et al. Atrial fibrillation and the risk of ischemic stroke: does it still matter in patients with a CHA2DS2-VASc score of 0 or 1? Stroke. 2012;43:2551–2555 DOI:10.1161/STROKEAHA.112.667865.; Ganesan AN, Chew DP, Hartshorne T, et al. The impact of atrial fibrillation A type on the risk of thromboembolism, mortality and bleeding: a systematic review and meta-analysis. Eur. Heart J. 2016,37,20:1591–1602. DOI:10.1093/eurheartj/ehw007.; Goette A, Kalman JM, Aguinaga L, et al. EHRA/HRS/APHRS/SOLAECE expert consensus on atrial cardiomyopathies: definition, characterization, and clinical implication. Heart Rhythm. 2017;14(1):e3-e40. DOI:10.1016/j.hrthm.2016.05.028.; Goldberger J, Arora R, Green D, et al. Evaluating the atrial myopathy underlying atrial fibrillation: identifying the arrhythmogenic and thrombogenic substrate. Circulation. 2015;132:278–291. DOI:10.1161/CIRCULATIONAHA.115.016795.; Kottkamp H. Human atrial fibrillation substrate: towards a specific fibrotic atrial cardiomyopathy. Eur. Heart J. 2013;34:2731–2738 DOI:10.1093/eurheartj/eht194.; Nattel S, Harada M. Atrial remodeling and atrial fibrillation: recent advances and translational perspectives. J Am Coll Cardiol. 2014;63:2335–45. DOI:10.1016/j.jacc.2014.02.555.; Santulli G, Iaccarino C, De Luca N, et al. Atrial fibrillation and microRNAs. Front Physiol. 2014;5:15. DOI:10.3389/fphys.2014.00015.; Marrouche NF, Wilber D, Hindricks G, et al. Association of atrial tissue fibrosis identified by delayed enhancement MRI and atrial fibrillation catheter ablation: the DECAAF study. JAMA. 2014;311:498–506. DOI:10.1001/jama.2014.3.; Kloosterman M, Oldgren J, Conen D, et al. Characteristics and outcomes of atrial fibrillation in patients without traditional risk factors: a RE-LY AF registry analysis. Europace. 2020;22:870–877. DOI:10.1093/europace/euz360.; Wijesurendra RS, Liu A, Eichhorn C, et al. Lone atrial fibrillation is associated with impaired left ventricular energetics that persists despite successful catheter ablation. Circulation. 2016;134:1068–1081. DOI:10.1161/CIRCULATIONAHA.116.022931.; Ntaios G. Embolic stroke of undetermined source: JACC review topic of the week. J Am Coll Cardiol. 2020;75:333–340. DOI:10.1016/j.jacc.2019.11.024.; Hart RG, Sharma M, Mundl H, et al. NAVIGATE ESUS Investigators. Rivaroxaban for stroke prevention after embolic stroke of undetermined source. N Engl J Med. 2018;378(23):2191-201. DOI:10.1056/NEJMoa1802686.; Diener HС, Sacco RL, Easton JD, et al. Committee R-SES and Investigators. Dabigatran for prevention of stroke after embolic stroke of undetermined source. N Engl J Med. 2019;380(20):1906-17. DOI:10.1056/NEJMoa1813959.; Healey JS, Gladstone DJ, Swaminathan B, et al. Recurrent stroke with rivaroxaban compared with aspirin according to predictors of atrial fibrillation: secondary analysis of the NAVIGATE ESUS randomized clinical trial. JAMA Neurol. 2019;76(7):764-73. DOI:10.1001/jamaneurol.2019.0617.; Longstreth WT, Kronmal RA, Thompson JLP, et al. Amino terminal pro-B-type natriuretic peptide, secondary stroke prevention, and choice of antithrombotic therapy. Stroke. 2013;44(3):714-9. DOI:10.1161/STROKEAHA.112.675942.; Kamel H, Longstreth W, Tirschwell D, et al. The AtRial Cardiopathy and Antithrombotic Drugs In prevention After cryptogenic stroke randomized trial: rationale and methods. Int J Stroke. 2019;14(2):207-14. DOI:10.1177/1747493018799981.; https://www.rpcardio.com/jour/article/view/2883
-
3Academic Journal
Authors: S. A. Chazov, S. A. Mekhryakov, A. A. Kulesh, L. I. Syromyatnikova, P. A. Astanin, С. А. Чазов, С. А. Мехряков, А. А. Кулеш, Л. И. Сыромятникова, П. А. Астанин
Contributors: The investigation has not been sponsored, Исследование не имело спонсорской поддержки
Source: Neurology, Neuropsychiatry, Psychosomatics; Vol 15, No 6 (2023); 40-47 ; Неврология, нейропсихиатрия, психосоматика; Vol 15, No 6 (2023); 40-47 ; 2310-1342 ; 2074-2711 ; 10.14412/2074-2711-2023-6
Subject Terms: магнитно-резонансная томография, atrial cardiomyopathy, magnetic resonance imaging, предсердная кардиомиопатия
File Description: application/pdf
Relation: https://nnp.ima-press.net/nnp/article/view/2137/1604; https://nnp.ima-press.net/nnp/article/view/2137/1620; Perera KS, Vanassche T, Bosch J, et al; ESUS Global Registry Investigators. Embolic strokes of undetermined source: Prevalence and patient features in the ESUS Global Registry. Int J Stroke. 2016 Jul;11(5):526-33. doi:10.1177/1747493016641967. Epub 2016 Apr 11.; Hart RG, Diener HC, Coutts SB, et al; Cryptogenic Stroke/ESUS International Working Group. Embolic strokes of undetermined source: the case for a new clinical construct. Lancet Neurol. 2014 Apr;13(4):42938. doi:10.1016/S1474-4422(13)70310-7; Кулеш АА, Демин ДА, Виноградов ОИ. Криптогенный инсульт. Часть 1: аорто-артериальная эмболия. Медицинский Совет. 2021;(4):78-87. doi:10.21518/2079-701X-2021-4-78-87; Кулеш АА, Демин ДА, Белопасова АВ и др. Криптогенный инсульт. Часть 2: парадоксальная эмболия. Медицинский Совет. 2021;(19):16-33. doi:10.21518/2079701X-2021-19-16-33; Демин ДА, Кулеш АА, Янишевский СН и др. Криптогенный инсульт. Часть 3: предсердная кардиопатия и скрытая фибрилляция предсердий. Медицинский Совет. 2022;(21):8-18. doi:10.21518/2079701X-2022-16-21-8-18; Ay H, Benner T, Arsava EM, et al. A computerized algorithm for etiologic classification of ischemic stroke: the Causative Classification of Stroke System. Stroke. 2007 Nov;38(11):2979-84. doi:10.1161/STROKEAHA.107.490896. Epub 2007 Sep 27.; Li TYW, Yeo LLL, Ho JSY, et al. Association of Electrocardiographic P-Wave Markers and Atrial Fibrillation in Embolic Stroke of Undetermined Source. Cerebrovasc Dis. 2021;50(1):46-53. doi:10.1159/000512179. Epub 2020 Dec 11.; Kamel H, Okin PM, Longstreth WT Jr, et al. Atrial cardiopathy: a broadened concept of left atrial thromboembolism beyond atrial fibrillation. Future Cardiol. 2015 May;11(3):323-31. doi:10.2217/fca.15.22; Jalini S, Rajalingam R, Nisenbaum R, et al. Atrial cardiopathy in patients with embolic strokes of unknown source and other stroke etiologies. Neurology. 2019 Jan 22;92(4):e288e294. doi:10.1212/WNL.0000000000006748. Epub 2018 Dec 5.; Silva AR, Pires C, Meira-Carvalho F, et al. Atrial cardiopathy predicts detection of atrial fibrillation in embolic stroke of undetermined source: real-life data. Neurol Sci. 2022 Apr;43(4):2383-6. doi:10.1007/s10072-02105692-3. Epub 2021 Oct 27.; Ntaios G, Perlepe K, Lambrou D, et al. Prevalence and Overlap of Potential Embolic Sources in Patients With Embolic Stroke of Undetermined Source. J Am Heart Assoc. 2019 Aug 6;8(15):e012858. doi:10.1161/JAHA.119.012858. Epub 2019 Jul 31.; Yaghi S, Boehme AK, Hazan R, et al. Atrial Cardiopathy and Cryptogenic Stroke: A Crosssectional Pilot Study. J Stroke Cerebrovasc Dis. 2016 Jan;25(1):110-4. doi:10.1016/j.jstrokecerebrovasdis.2015.09.001. Epub 2015 Oct 21.; Tan BYQ, Ho JSY, Sia CH, et al. Left Atrial Volume Index Predicts New-Onset Atrial Fibrillation and Stroke Recurrence in Patients with Embolic Stroke of Undetermined Source. Cerebrovasc Dis. 2020;49(3):285-91. doi:10.1159/000508211. Epub 2020 Jun 17.; Jordan K, Yaghi S, Poppas A, et al. Left Atrial Volume Index Is Associated With Cardioembolic Stroke and Atrial Fibrillation Detection After Embolic Stroke of Undetermined Source. Stroke. 2019 Aug;50(8):1997-2001. doi:10.1161/STROKEAHA.119.025384. Epub 2019 Jun 13.; Hart RG, Sharma M, Mundl H, et al; NAVIGATE ESUS Investigators. Rivaroxaban for Stroke Prevention after Embolic Stroke of Undetermined Source. N Engl J Med. 2018 Jun 7;378(23):2191-201. doi:10.1056/NEJMoa1802686. Epub 2018 May 16.; Kirchhof P, Toennis T, Goette A, et al. Anticoagulation with Edoxaban in Patients with Atrial High-Rate Episodes. N Engl J Med. 2023;10.1056/NEJMoa2303062. doi:10.1056/NEJMoa2303062. Epub 2023 Aug 25.; Perlepe K, Sirimarco G, Strambo D, et al. Left atrial diameter thresholds and new incident atrial fibrillation in embolic stroke of undetermined source. Eur J Intern Med. 2020 May;75:30-4. doi:10.1016/j.ejim.2020.01.002. Epub 2020 Jan 15.; Tajmirriahi M, Salari P, Saadatnia M. Left atrial function index in embolic stroke of undetermined source: A case-control study. Neurol Asia. 2022;27(2):275-9. doi:10.54029/2022cnz; Poli S, Diedler J, Härtig F, et al. Insertable cardiac monitors after cryptogenic stroke – a risk factor based approach to enhance the detection rate for paroxysmal atrial fibrillation. Eur J Neurol. 2016 Feb;23(2):375-81. doi:10.1111/ene.12843. Epub 2015 Oct 16.; Kneihsl M, Bisping E, Scherr D, et al. Predicting atrial fibrillation after cryptogenic stroke via a clinical risk score-a prospective observational study. Eur J Neurol. 2022 Jan;29(1):149-57. doi:10.1111/ene.15102. Epub 2021 Sep 23.; Ntaios G, Perlepe K, Lambrou D, et al. Supraventricular Extrasystoles on Standard 12lead Electrocardiogram Predict New Incident Atrial Fibrillation after Embolic Stroke of Undetermined Source: The AF-ESUS Study. J Stroke Cerebrovasc Dis. 2020 Apr;29(4):104626. doi:10.1016/j.jstrokecerebrovasdis.2019.104626. Epub 2020 Jan 15.; Vollmuth C, Stoesser S, Neugebauer H, et al. MR-imaging pattern is not a predictor of occult atrial fibrillation in patients with cryptogenic stroke. J Neurol. 2019 Dec;266(12):3058-64. doi:10.1007/s00415-019-09524-5. Epub 2019 Sep 11. Erratum in: J Neurol. 2020 Oct;267(10):3117.; Di Meglio L, Derraz I, Solonomenjanahary M, et al; compoCLOT Research Investigators group. Two-layered susceptibility vessel sign is associated with biochemically quantified thrombus red blood cell content. Eur J Neurol. 2020 Jul;27(7):1264-71. doi:10.1111/ene.14241. Epub 2020 May 3.; Kang DW, Jeong HG, Kim DY, et al. Prediction of Stroke Subtype and Recanalization Using Susceptibility Vessel Sign on Susceptibility-Weighted Magnetic Resonance Imaging. Stroke. 2017 Jun;48(6):1554-9. doi:10.1161/STROKEAHA.116.016217. Epub 2017 Apr 21.; Bourcier R, Derraz I, Delasalle B, et al; THRACE investigators. Susceptibility Vessel Sign and Cardioembolic Etiology in the THRACE Trial. Clin Neuroradiol. 2019 Dec;29(4):685-92. doi:10.1007/s00062-0180699-8. Epub 2018 Jun 12.; Alhazmi H, Bani-Sadr A, Bochaton T, et al. Large vessel cardioembolic stroke and embolic stroke of undetermined source share a common profile of matrix metalloproteinase-9 level and susceptibility vessel sign length. Eur J Neurol. 2021 Jun;28(6):1977-83. doi:10.1111/ene.14806. Epub 2021 Apr 17.; Del Brutto VJ, Diener HC, Easton JD, et al. Predictors of Recurrent Stroke After Embolic Stroke of Undetermined Source in the RE-SPECT ESUS Trial. J Am Heart Assoc. 2022 Jun 7;11(11):e023545. doi:10.1161/JAHA.121.023545. Epub 2022 Jun 3.; Hou Y, Elmashad A, Staff I, et al. Potential Embolic Sources Differ in Patients With Embolic Stroke of Undetermined Source According to Age: A 15-Year Study. Front Neurol. 2022 May 17;13:860827. doi:10.3389/fneur.2022.860827; Jagadeesan V, Culver A, Raiker N, et al. Left Atrial Dilation and Risk of One-Year Readmission after Embolic Stroke of Undetermined Source. J Stroke Cerebrovasc Dis. 2020 Aug;29(8):104975. doi:10.1016/j.jstrokecerebrovasdis.2020.104975. Epub 2020 Jun 9.
-
4Academic Journal
Authors: G. R. Ramazanov, E. A. Kovaleva, R. A. Novikov, S. S. Petrikov, Г. Р. Рамазанов, Э. А. Ковалева, Р. А. Новиков, С. С. Петриков
Source: Russian Sklifosovsky Journal "Emergency Medical Care"; Том 11, № 3 (2022); 493-500 ; Журнал им. Н.В. Склифосовского «Неотложная медицинская помощь»; Том 11, № 3 (2022); 493-500 ; 2541-8017 ; 2223-9022
Subject Terms: патогенез ишемического инсульта, cryptogenic stroke, atrial cardiomyopathy, pathogenesis of ischemic stroke, криптогенный инсульт, предсердная кардиомиопатия
File Description: application/pdf
Relation: https://www.jnmp.ru/jour/article/view/1452/1206; https://www.jnmp.ru/jour/article/view/1452/1224; Hart RG, Catanese L, Perera KS, Ntaios G, Connolly SJ. Embolic stroke of undetermined source: a systematic review and clinical update. Stroke. 2017;48(4):867–872. PMID:28265016 https://doi.org/10.1161/STROKEAHA.116.016414; Hart RG, Sharma M, Mundl H, Kasner SE, Bangdiwala SI, Berkowitz SD, et al; NAVIGATE ESUS Investigators. Rivaroxaban for Stroke Prevention after Embolic Stroke of Undetermined Source. N Engl J Med. 2018;378(23):2191–2201. PMID:29766772 https://doi.org/10.1056/NEJMoa1802686; Diener HC, Sacco RL, Easton JD, Granger CB, Bernstein RA, Uchiyama S, et al.; RE-SPECT ESUS Steering Committee and Investigators. Dabigatran for Prevention of Stroke after Embolic Stroke of Undetermined Source. N Engl J Med. 2019;380(20):1906–1917. PMID:31091372 https://doi.org/10.1056/NEJMoa1813959; Sanna T, Diener HC, Passman RS, Di Lazzaro V, Bernstein RA, Morillo CA, et al; CRYSTAL AF Investigators. Cryptogenic stroke and underlying atrial fibrillation. N Engl J Med. 2014;370(26):2478–2486. PMID:24963567 https://doi.org/10.1056/NEJMoa1313600; Brambatti M, Connolly SJ, Gold MR, Morillo CA, Capucci A, Muto C, et al. Temporal relationship between subclinical atrial fibrillation and embolic events. Circulation. 2014;129(21):2094–2099. PMID:24633881 https://doi.org/10.1161/CIRCULATIONAHA.113.007825; Daoud EG, Glotzer TV, Wyse DG, Ezekowitz MD, Hilker C, Koehler J, et al. Temporal relationship of atrial tachyarrhythmias, cerebrovascular events, and systemic emboli based on stored device data: A subgroup analysis of trends. Heart Rhythm. 2011;8(9):1416–1423. PMID:21699833 https://doi.org/10.1016/j.hrthm.2011.04.022; Yaghi S, Kamel H, Elkind MSV. Atrial cardiopathy: a mechanism of cryptogenic stroke. Expert Rev Cardiovasc Ther. 2017;15(8):591–599. PMID:28718666 https://doi.org/10.1080/14779072.2017.1355238; Warraich HJ, Gandhavadi M, Manning WJ. Mechanical discordance of the left atrium and appendage: A novel mechanism of stroke in paroxysmal atrial fibrillation. Stroke. 2014;45(5):1481–1484. PMID:24643411 https://doi.org/10.1161/STROKEAHA.114.004800; Boeckh-Behrens T, Kleine JF, Zimmer C, Neff F, Scheipl F, Pelisek J, et al. Thrombus Histology Suggests Cardioembolic Cause in Cryptogenic Stroke. Stroke. 2016;47(7):1864–1871. PMID:27197854 https://doi.org/10.1161/STROKEAHA.116.013105; Brigden W. Uncommon myocardial diseases; the non-coronary cardiomyopathies. Lancet. 1957;273(7008):1243–1249. PMID:13492617 https://doi.org/10.1016/s0140-6736(57)91537-4; Nagle RE, Smith B, Williams DO. Familial atrial cardiomyopathy with heart block. Br Heart J. 1972;34(2):205. PMID:5007810; Goette A, Kalman JM, Aguinaga L, Akar J, Cabrera JA, Chen SA, et al. EHRA/HRS/APHRS/SOLAECE expert consensus on atrial cardiomyopathies: definition, characterization, and clinical implication. Heart Rhythm. 2017;14(1):e3–e40. PMID:27320515 https://doi.org/10.1016/j.hrthm.2016.05.028; Ning Y, Tse G, Luo G, Li G. Atrial Cardiomyopathy: An Emerging Cause of the Embolic Stroke of Undetermined Source. Front Cardiovasc Med. 2021;8:674612. PMID:34434973 https://doi.org/10.3389/fcvm.2021.674612; Kamel H, Longstreth WT Jr, Tirschwell DL, Kronmal RA, Broderick JP, Palesch YY, et al. The AtRial cardiopathy and antithrombotic drugs in prevention after cryptogenic stroke randomized trial: rationale and methods. Int J Stroke. 2019;14(2):207–214. PMID:30196789 https://doi.org/10.1177/1747493018799981; Kamel H, Okin PM, Longstreth WT Jr, Elkind MS, Soliman EZ. Atrial cardiopathy: a broadened concept of left atrial thromboembolism beyond atrial fibrillation. Future Cardiol. 2015;11(3):323–331. PMID:26021638 https://doi.org/10.2217/fca.15.22; Kamel H, Okin PM, Elkind MS, Iadecola C. Atrial fibrillation and mechanisms of stroke: time for a new model. Stroke. 2016;47(3):895–900. PMID:26786114 https://doi.org/10.1161/STROKEAHA.115.012004; Ahmad MI, Singleton MJ, Bhave PD, Kamel H, Soliman EZ. Atrial cardiopathy and stroke mortality in the general population. Int J Stroke. 2020;15(6):650–656. PMID:31530133 https://doi.org/10.1177/1747493019876543; Kamel H, Bartz TM, Elkind MSV, Okin PM, Thacker EL, Patton KK, et al. Atrial cardiopathy and the risk of ischemic stroke in the CHS (Cardiovascular Health Study). Stroke. 2018;49(4):980–986. PMID:29535268 https://doi.org/10.1161/STROKEAHA.117.020059; Sebasigari D, Merkler A, Guo Y, Gialdini G, Kummer B, Hemendinger M, et al. Biomarkers of Atrial Cardiopathy and Atrial Fibrillation Detection on Mobile Outpatient Continuous Telemetry after Embolic Stroke of Undetermined Source. J Stroke Cerebrovasc Dis. 2017;26(6):1249–1253. PMID:28237125 https://doi.org/10.1016/j.jstrokecerebrovasdis.2017.01.016; Yaghi S, Moon YP, Mora-McLaughlin C, Willey JZ, Cheung K, Di Tullio MR, et al. Left atrial enlargement and stroke recurrence: The northern manhattan stroke study. Stroke. 2015;46(6):1488–1493. PMID:25908460 https://doi.org/10.1161/STROKEAHA.115.008711; Black IW. Spontaneous echo contrast: Where there’s smoke there’s fire. Echocardiography. 2000;17(4):373–382. PMID:10979010 https://doi.org/10.1111/j.1540-8175.2000.tb01153.x; Arauz A, Arteaga C, Zapata-Gómez C, Ramos-Ventura C, Méndez B, Otiniano-Sifuentes R, et al. Embolic stroke of undetermined source: beyond atrial fibrillation. Neurologia (Engl Ed). 2019: S0213-4853(19)30056-8. PMID:31060753 https://doi.org/10.1016/j.nrl.2019.03.008; Di Tullio MR, Sacco RL, Sciacca RR, Homma S. Left atrial size and the risk of ischemic stroke in an ethnically mixed population. Stroke. 1999;30(10):2019–2024. PMID:10512901 https://doi.org/10.1161/01.str.30.10.2019; Chen J, Gao F, Liu W. Atrial cardiopathy in embolic stroke of undetermined source. Brain Behav. 2021;11(6):e02160. PMID:33942558 https://doi.org/10.1002/brb3.2160; Jalini S, Rajalingam R, Nisenbaum R, Javier AD, Woo A, Pikula A. Atrial cardiopathy in patients with embolic strokes of unknown source and other stroke etiologies. Neurology. 2019;92(4):e288–e294. PMID:30518556 https://doi.org/10.1212/WNL.0000000000006748; Lee JM, Shim J, Uhm JS, Kim YJ, Lee HJ, Pak HN, et al. Impact of increased orifice size and decreased flow velocity of left atrial appendage on stroke in nonvalvular atrial fibrillation. Am J Cardiol. 2014;113(6):963–969. PMID:24462064 https://doi.org/10.1016/j.amjcard.2013.11.058; Di Biase L, Santangeli P, Anselmino M, Mohanty P, Salvetti I, Gili S, et al. Does the left atrial appendage morphology correlate with the risk of stroke in patients with atrial fibrillation? Results from a multicenter study. J Am Coll Cardiol. 2012;60(6):531–538. PMID:22858289 https://doi.org/10.1016/j.jacc.2012.04.032; Lee JM, Seo J, Uhm JS, Kim YJ, Lee HJ, Kim JY, et al. Why is left atrial appendage morphology related to strokes? An analysis of the flow velocity and orifice size of the left atrial appendage. J Cardiovasc Electrophysiol. 2015;26(9):922–927. PMID:25959871 https://doi.org/10.1111/jce.12710; Kishima H, Mine T, Ashida K, Sugahara M, Kodani T, Masuyama T. Does left atrial appendage morphology influence left atrial appendage flow velocity? Circ J. 2015;79(8):1706–1711. PMID:25959433 https://doi.org/10.1253/circj.CJ-14-1380; Yamamoto M, Seo Y, Kawamatsu N, Sato K, Sugano A, MachinoOhtsuka T, et al. Complex left atrial appendage morphology and left atrial appendage thrombus formation in patients with atrial fibrillation. Circ Cardiovasc Imaging. 2014;7(2):337–343. PMID:24523417 https://doi.org/10.1161/CIRCIMAGING.113.001317; Akoum N, Fernandez G, Wilson B, Mcgann C, Kholmovski E, Marrouche N. Association of atrial fibrosis quantified using LGE-MRI with atrial appendage thrombus and spontaneous contrast on transesophageal echocardiography in patients with atrial fibrillation. J Cardiovasc Electrophysiol. 2013;24(10):1104–1109. PMID:23844972 https://doi.org/10.1111/jce.12199; Marrouche NF, Wilber D, Hindricks G, Jais P, Akoum N, Marchlinski F, et al. Association of atrial tissue fibrosis identified by delayed enhancement MRI and atrial fibrillation catheter ablation: the DECAAF study. JAMA. 2014;311(5):498–506. PMID:24496537 https://doi.org/10.1001/jama.2014.3; Daccarett M, Badger TJ, Akoum N, Burgon NS, Mahnkopf C, Vergara G, et al. Association of left atrial fibrosis detected by delayed-enhancement magnetic resonance imaging and the risk of stroke in patients with atrial fibrillation. J Am Coll Cardiol. 2011;57(7):831–838. PMID:21310320 https://doi.org/10.1016/j.jacc.2010.09.049; Fonseca AC, Alves P, Inácio N, Marto JP, Viana-Baptista M, PinhoE-Melo T, et al. Patients with Undetermined Stroke Have Increased Atrial Fibrosis: A Cardiac Magnetic Resonance Imaging Study. Stroke. 2018;49(3):734–737. PMID:29371431 https://doi.org/10.1161/STROKEAHA.117.019641; Fonseca AC, Marto JP, Pimenta D, Guimarães T, Alves PN, Inácio N, et. al. Undetermined stroke genesis and hidden cardiomyopathies determined by cardiac magnetic resonance. Neurology. 2020;94(1):e107–e113. PMID:31792090 https://doi.org/10.1212/WNL.0000000000008698; Montalvo M, Tadi P, Merkler A, Gialdini G, Martin-Schild S, Navalkele D, et al. PR interval prolongation and cryptogenic stroke: a multicenter retrospective study. J Stroke Cerebrovasc Dis. 2017;26(10):2416–2420. PMID:28666806 https://doi.org/10.1016/j.jstrokecerebrovasdis.2017.05.036; Kamel H, Soliman EZ, Heckbert SR, Kronmal RA, Longstreth WT Jr, Nazarin S, et al. P-wave morphology and the risk of incident ischemic stroke in the Multi-Ethnic Study of Atherosclerosis. Stroke. 2014;45(9):2786–2788. PMID:25052322 https://doi.org/10.1161/STROKEAHA.114.006364; He J, Tse G, Korantzopoulos P, Letsas KP, Ali-Hasan-Al-Saegh S, Kamel H, et al. P-wave indices and risk of ischemic stroke: a systematic review and meta-analysis. Stroke. 2017;48(8):2066–2072. PMID:28679858 https://doi.org/10.1161/STROKEAHA.117.017293; Kamel H, Elkind MS, Bhave PD, Navi BB, Okin PM, Iadecola C, et al. Paroxysmal supraventricular tachycardia and the risk of ischemic stroke. Stroke. 2013;44(6):1550–1554. PMID:23632982 https://doi.org/10.1161/STROKEAHA.113.001118; Hamer ME, Wilkinson WE, Clair WK, Page RL, McCarthy EA, Pritchett EL. Incidence of symptomatic atrial fibrillation in patients with paroxysmal supraventricular tachycardia. J Am Coll Cardiol. 1995;25(5):984–988. PMID:7897142 https://doi.org/10.1016/0735-1097(94)00512-o; Thijs VN, Brachmann J, Morillo CA, Passman RS, Sanna T, Bernstein RA, et al. Predictors for atrial fibrillation detection after cryptogenic stroke: Results from crystal af. Neurology. 2016;86(3):261–269. PMID:26683642 https://doi.org/10.1212/WNL.0000000000002282; Kitkungvan D, Spodick DH. Interatrial block: is it time for more attention? J Electrocardiol. 2009;42(6):687–692. PMID:19698951 https://doi.org/10.1016/j.jelectrocard.2009.07.016; Ariyarajah V, Asad N, Tandar A, Spodick DH. Interatrial block: pandemic prevalence, significance, and diagnosis. Chest. 2005;128(2):970–975. PMID:16100193 https://doi.org/10.1378/chest.128.2.970; Goyal SB, Spodick DH. Electromechanical dysfunction of the left atrium associated with interatrial block. Am Heart J. 2001;142(5):823–827. PMID:11685169 PMID: https://doi.org/10.1067/mhj.2001.118110; Ariyarajah V, Spodick DH. The Bachmann bundle and interatrial conduction. Cardiol Rev. 2006;14(4):194–199. PMID:16788332 https://doi.org/10.1097/01.crd.0000195221.26979.2b; Cotter PE, Martin PJ, Pugh PJ, Warburton EA, Cheriyan J, Belham M. Increased Incidence of Interatrial Block in Younger Adults with Cryptogenic Stroke and Patent Foramen Ovale. Cerebrovasc Dis Extra. 2011;1(1):36–43. PMID:22566981 https://doi.org/10.1159/000327346; Arboix A, Martí L, Dorison S, Sánchez MJ. Bayes syndrome and acute cardioembolic ischemic stroke. World J Clin Cases. 2017;5(3):93–101. PMID:28352633 https://doi.org/10.12998/wjcc.v5.i3.93; Martinez-Selles M, Masso-van Roessel A, Alvarez-Garcia J, Garcia de la Villa B, Cruz-Jentoft AJ, Vidan MT, et al. Interatrial block and atrial arrhythmias in centenarians: Prevalence, associations, and clinical implications. Heart Rhythm. 2016;13(3):645–651. PMID:26520207 https://doi.org/10.1016/j.hrthm.2015.10.034; Cha JJ, Chung H, Uhm JS, Joung B, Pak HN, MH Lee, et al. Multiple atrial premature contractions predict stroke recurrence in patients with cryptogenic stroke and concomitant non-sustained atrial tachycardia. Int J Arrhythm. 2020;21:5. https://doi.org/10.1186/s42444-020-00014-8; Rutten JH, Mattace-Raso FU, Steyerberg EW, Lindemans J, Hofman A, Wieberdink RG, et al. Amino-terminal pro-b-type natriuretic peptide improves cardiovascular and cerebrovascular risk prediction in the population: The Rotterdam study. Hypertension. 2010;55(3):785–791. PMID:20083731 https://doi.org/10.1161/HYPERTENSIONAHA.109.143313; Rodríguez-Yáñez M, Arias-Rivas S, Santamaría-Cadavid M, Sobrino T, Castillo J, Blanco M. High pro-BNP levels predict the occurrence of atrial fibrillation after cryptogenic stroke. Neurology. 2013;81(5):444–447. PMID:23803318 https://doi.org/10.1212/WNL.0b013e31829d8773; Kerr G, Ray G, Wu O, Stott DJ, Langhorne P. Elevated troponin after stroke: a systematic review. Cerebrovasc Dis. 2009;28(3):220–226. PMID:19571535 https://doi.org/10.1159/000226773; Scheitz JF, Nolte CH, Laufs U, Endres M. Application and interpretation of high-sensitivity cardiac troponin assays in patients with acute ischemic stroke. Stroke. 2015;46(4):1132–1140. PMID:25737317 https://doi.org/10.1161/STROKEAHA.114.007858; Merkler AE, Gialdini G, Murthy SB, Salehi Omran S, Moya A, Lerario MP, et al. Association Between Troponin Levels and Embolic Stroke of Undetermined Source. J Am Heart Assoc. 2017;6(9):e005905. PMID:28939703 https://doi.org/10.1161/JAHA.117.005905; Mochmann HC, Scheitz JF, Petzold GC, Haeusler KG, Audebert HJ, Laufs U, et al. Coronary Angiographic Findings in Acute Ischemic Stroke Patients with Elevated Cardiac Troponin. The Troponin Elevation in Acute Ischemic Stroke (TRELAS) Study. Circulation. 2016;133(13):1264–1271. PMID:26933082 https://doi.org/10.1161/CIRCULATIONAHA.115.018547; https://www.jnmp.ru/jour/article/view/1452
-
5Academic Journal
Source: The Russian Archives of Internal Medicine; Том 11, № 5 (2021); 389-400 ; Архивъ внутренней медицины; Том 11, № 5 (2021); 389-400 ; 2411-6564 ; 2226-6704
Subject Terms: предсердная кардиомиопатия, sinus rhythm recovery, obesity, weight control, atrial cardiomyopathy, восстановление синусового ритма, ожирение, контроль массы тела
File Description: application/pdf
Relation: https://www.medarhive.ru/jour/article/view/1302/1057; https://www.medarhive.ru/jour/article/view/1302/1064; Филатов А.Г., Тарашвили Э.Г. Эпидемиология и социальная значимость фибрилляции предсердий. Анналы аритмологии. 2012; 9(2): 5-13.; Nabauer M, Gerth A, Limbourg T. et al. The Registry of the German Competence NETwork on Atrial Fibrillation: patient characteristics and initial management. Europace. 2008; 11(4): 423-434. doi:10.1093/europace/eun369.; Tsang TS, Barnes ME, Miyasaka Y. et al. Obesity as a risk factor for the progression of paroxysmal to permanent atrial fibrillation: a longitudinal cohort study of 21 years. Eur Heart J. 2008; 29(18): 2227-2233. doi:10.1093/eurheartj/ehn324.; Wong CX, Sullivan T, Sun MT et al. Obesity and the Risk of Incident, Post Operative, and Post-Ablation Atrial Fibrillation: A Meta-Analysis of 626 603 Individuals in 51 Studies. JACC Сlinical electrophysiology. 2015; 1(3): 139–152. doi:10.1016/j.jacep.2015.04.004.; Голухова Е.З., Громова О.И., Булаева Н.И. и др. Эпикардиальный жир и фибрилляция предсердий : роль профиброгенных медиаторов. Кардиология. 2018; 58(7): 59–65. doi.org/10.18087/cardio.2018.7.10145.; Abed HS, Wittert GA, Leong DP, et al. Effect of weight reduction and cardiometabolic risk factor management on symptom burden and severity in patients with atrial fibrillation: a randomized clinical trial. JAMA. 2013; 310(19): 2050–2060. doi:10.1001/jama.2013.280521.; Pathak RK, Middeldorp ME, Lau DH, et al. Aggressive risk factor reduction study for atrial fibrillation and implications for the outcome of ablation: the ARREST-AF cohort study. J Am Coll Cardiol. 2014; 64(21): 2222–2231. doi:10.1016/j.jacc.2014.09.028.; Hindricks G, Potpara T, Dagres N. et al. 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association of CardioThoracic Surgery (EACTS). Eur Heart J. 2021; 42(5): 373-498. doi:10.1093/eurheartj/ehaa612.; Jensen MD, Ryan DH, Apovian CM, et al. 2013 AHA/ACC/TOS guideline for the management of overweight and obesity in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and The Obesity Society. J Am Coll Cardiol. 2014; 63(25): 2985–3023. doi:10.1016/j. jacc.2013.11.004.; de Vos CB, Pisters R, Nieuwlaat R. et al. Progression from paroxysmal to persistent atrial fibrillation clinical correlates and prognosis. J Am Coll Cardiol. 2010; 55(8): 725–731. doi:10.1016/j.jacc.2009.11.040.; Schotten U, Verheule S, Kirchhof P. et al. Pathophysiological mechanisms of atrial fibrillation: a translational appraisal. Physiol Rev. 2011; 91(1): 265–325. doi:10.1152/physrev.00031.2009.; Аракелян М.Г., Бокерия Л.А., Васильева Е.Ю. и др. Фибрилляция и трепетание предсердий. Клинические рекомендации Министерства здравоохранения Российской Федерации. Москва. 2020; 1-185.; Nattel S, Harada M. Atrial remodeling and atrial fibrillation: recent advances and translational perspectives. J Am Coll Cardiol. 2014; 63(22): 2335–2345. doi:10.1016/j.jacc.2014.02.555.; Kannel WB, Abbott RD, Savage DD. et al. Coronary heart disease and atrial fibrillation: The Framingham Study, AM Heart J. 1983; 106(2): 389-396. doi:10.1016/0002-8703(83)90208-9.; Голицын С.П., Панченко Е.П., Кропачева Е.С. и др. Диагностика и лечение фибрилляции предсердий. Евразийский кардиологический журнал. 2019; (4): 4-85.; Camm A.J., Kirchhof P., Lip G.Y.H. et al. Guidelines for the management of atrial fibrillation. The Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC). Eur Heart J. 2010; 31(19): 2369-2429. doi:10.1093/eurheartj/ehq278.; Stiles MK, John B, Wong CX. et al. Paroxysmal lone atrial fibrillation is associated with an abnormal atrial substrate: characterizing the “second factor”. J Am Coll Cardiol. 2009; 53(14): 1182–91. doi:10.1016/j.jacc.2008.11.054.; Teh AW, Kistler PM, Lee G. et al. Long-term effects of catheter ablation for lone atrial fibrillation: progressive atrial electroanatomic substrate remodeling despite successful ablation. Heart Rhythm. 2012;9(4):473–480. doi:10.1016/j.hrthm.2011.11.013.; Li D, Fareh S, Leung TK, Nattel S. Promotion of atrial fibrillation by heart failure in dogs: atrial remodeling of a different sort. Circulation. 1999; 100(1): 87–95. doi:10.1161/01.cir.100.1.87.; Ревишвили А.Ш., Рзаев Ф.Г., Горев М.В. и др. Диагностика и лечение фибрилляции предсердий. Клинические рекомендации. Москва. 2017; 201с.; Бокерия Л.А., Бокерия О.Л., Глухова Е.З. и др. Фибрилляция предсердий. Клинические рекомендации. Москва. 2017; 65с.; Дедов И.И., Мокрышева Н.Г., Мельниченко Г.А., и др. Ожирение. Клинические рекомендации Министерства здравоохранения Российской Федерации. Москва. 2020; 43с.; Garvey W.T., Mechanick J.I., Brett E.M. et al. Reviewers of the AACE/ACE Obesity Clinical Practice Guidelines. American Association of Clinical Endocrinologists and American College of Endocrinology comprehensive clinical practice guidelines fo r medical care of patients with obesity. Endocrine Practice. 2016; 22(3): 1-203.; Auer J. Fat: an emerging player in the field of atrial fibrillation. European Heart Journal. 2016; 38(1): 62-65. doi:10.1093/eurheartj/ehw013.; De Vos CB, Breithardt G, Camm AJ. et al. Progression of atrial fibrillation in the REgistry on Cardiac rhythm disORDers assessing the control of Atrial Fibrillation cohort: clinical correlates and the effect of rhythm-control therapy. Am Heart J. 2012; 163(5): 887–893. doi:10.1016/j.ahj.2012.02.015.; https://www.medarhive.ru/jour/article/view/1302